Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Open Forum Infectious Diseases
|
February 19, 2021
Preprocedural SARS-CoV-2 Testing to Sustain Medically Needed Health Care Delivery During the COVID-19 Pandemic: A Prospective Observational Study
Ghady Haidar, Ashley Ayres, Wendy C King, et al.
Medical Mycology Case Reports
|
April 30, 2019
<i>Rasamsonia</i> sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel <i>Rasamsonia argillacea</i> species complex involving the heart
Ahmed Babiker, Nupur Gupta, Connie F C Gibas, et al.
Jac-Antimicrobial Resistance
|
September 6, 2024
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline
Ghady Haidar, Ellen G Kline, Georgios D Kitsios, et al.
The Lancet. Infectious Diseases
|
August 14, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to action
Joshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, et al.
Journal of Clinical Microbiology
|
November 24, 2017
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
Ryan K Shields, Cornelius J Clancy, A William Pasculle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2016
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K Shields, Brian A Potoski, Ghady Haidar, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Daptomycin-Resistant <i>Enterococcus</i> Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation
Rachael A Lee, Jason Goldman, Ghady Haidar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 23, 2019
Heart or lung transplant outcomes in HIV-infected recipients
Christine E Koval, Maryjane Farr, Jill Krisl, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 30, 2025
Donor Lung <i>Prevotella</i> Predicts Favorable Early FEV1 Trajectory Following Lung Transplantation
Mark E Snyder, Ghady Haidar, Kelvin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2024
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia
Sunish Shah, Ellen G Kline, Ghady Haidar, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Open Forum Infectious Diseases
|
February 19, 2021
Preprocedural SARS-CoV-2 Testing to Sustain Medically Needed Health Care Delivery During the COVID-19 Pandemic: A Prospective Observational Study
Ghady Haidar, Ashley Ayres, Wendy C King, et al.
Medical Mycology Case Reports
|
April 30, 2019
<i>Rasamsonia</i> sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel <i>Rasamsonia argillacea</i> species complex involving the heart
Ahmed Babiker, Nupur Gupta, Connie F C Gibas, et al.
Jac-Antimicrobial Resistance
|
September 6, 2024
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline
Ghady Haidar, Ellen G Kline, Georgios D Kitsios, et al.
The Lancet. Infectious Diseases
|
August 14, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to action
Joshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, et al.
Journal of Clinical Microbiology
|
November 24, 2017
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
Ryan K Shields, Cornelius J Clancy, A William Pasculle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2016
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K Shields, Brian A Potoski, Ghady Haidar, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Daptomycin-Resistant <i>Enterococcus</i> Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation
Rachael A Lee, Jason Goldman, Ghady Haidar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 23, 2019
Heart or lung transplant outcomes in HIV-infected recipients
Christine E Koval, Maryjane Farr, Jill Krisl, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 30, 2025
Donor Lung <i>Prevotella</i> Predicts Favorable Early FEV1 Trajectory Following Lung Transplantation
Mark E Snyder, Ghady Haidar, Kelvin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2024
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia
Sunish Shah, Ellen G Kline, Ghady Haidar, et al.
Page
of 10